Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Jan 25 | ALXO ALX Oncology | Stock Option Common Stock | Grant | Acquire A | No | No | 1.65 | 40,400 | 66.66 k | 40,400 |
22 Jul 24 | ARTV Artiva Biotherapeutics, Inc. Common Stock | Common Stock | Buy | Acquire P | No | No | 12 | 416,666 | 5.00 mm | 1,936,637 |
22 Jul 24 | ARTV Artiva Biotherapeutics, Inc. Common Stock | Common Stock | Other | Acquire J | No | No | 0 | 461,687 | 0.00 | 1,519,971 |
22 Jul 24 | ARTV Artiva Biotherapeutics, Inc. Common Stock | Common Stock | Conversion | Acquire C | No | No | 0 | 214,692 | 0.00 | 1,058,284 |
22 Jul 24 | ARTV Artiva Biotherapeutics, Inc. Common Stock | Common Stock | Conversion | Acquire C | No | No | 0 | 843,592 | 0.00 | 843,592 |
22 Jul 24 | ARTV Artiva Biotherapeutics, Inc. Common Stock | Series B Convertible Preferred Stock Common Stock | Conversion | Dispose C | No | No | 0 | 214,692 | 0.00 | 0 |
22 Jul 24 | ARTV Artiva Biotherapeutics, Inc. Common Stock | Series A Convertible Preferred Stock Common Stock | Conversion | Dispose C | No | No | 0 | 843,592 | 0.00 | 0 |
13 Jun 24 | ALXO ALX Oncology | Stock Option Common Stock | Grant | Acquire A | No | No | 8.44 | 20,200 | 170.49 k | 20,200 |
19 Sep 23 | RYZB RayzeBio | Common Stock | Conversion | Acquire C | No | No | 0 | 247,343 | 0.00 | 5,158,162 |
19 Sep 23 | RYZB RayzeBio | Common Stock | Conversion | Acquire C | No | No | 0 | 1,123,862 | 0.00 | 4,910,819 |